Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2485 ARTÍCULOS , VIENDO DEL 421 AL 435

Acetylcholinesterase as a Multifunctional Target in Amyloid-Driven Neurodegeneration: From Dual-Site Inhibitors to Anti-Agregation Strategies

Grabowska W, Bijak M, Szelenberger R, Gorniak L, Podogrocki M, Harmata P, Cichon N.

Int J Mol Sci. 2025 Sep 7;26(17):8726. doi: 10.3390/ijms26178726.

Interplay of Glut1 alteration and Alzheimer's disease: A narrative review on glucose transport and energy metabolism

Fakorede S, Sodiq TA, Ajagbe AO, Adeleke AJ, Edafetanure-Ibeh OM, Awobona TA, Aborode AT.

J Alzheimers Dis. 2025 Nov;108(2):470-486. doi: 10.1177/13872877251377793. Epub 2025 Sep 12.

Research Progress in Application of Sensory Stimulation Therapy in Patients With Alzheimer's Disease

Liu P, Zhang Y, Meng QH.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2025 Aug;47(4):621-627. doi: 10.3881/j.issn.1000-503X.16375.

Medicinal chemistry-based novel herapeutics for Tauopathies in Alzheimer's disease

Chinnathambi S, Malik S, Chandrashekar M, Kumurappan M.

Adv Protein Chem Struct Biol. 2025;147:151-175. doi: 10.1016/bs.apcsb.2024.09.001. Epub 2024 Sep 20.

Tau protein structure and dynamics

Chinnathambi S, Velmurugan G, Chandrashekar M.

Adv Protein Chem Struct Biol. 2025;147:241-258. doi: 10.1016/bs.apcsb.2024.09.002. Epub 2024 Sep 20.

Mapping the pathogenic nexus: Gene overlap and protein interaction networks in Alzheimer's and breast cancer as a precursor to protein structure prediction and analysis

Chowdhury MR, Deepa VS, Raja VK.

Adv Protein Chem Struct Biol. 2025;147:275-331. doi: 10.1016/bs.apcsb.2024.11.007. Epub 2025 Apr 4.

Role and relation of cell death in Alzheimer's disease

Hoang DA, Le DA, Do TMH, Than VT.

Prog Mol Biol Transl Sci. 2025;217:263-303. doi: 10.1016/bs.pmbts.2025.06.024. Epub 2025 Jul 1.

Targeting Metabolic Dysregulation in Alzheimer's Disease: A Potential Therapeutic Strategy

Barnwal N, Dubey S, Tiwari P.

Curr Drug Metab. 2025;26(7):455-471. doi: 10.2174/0113892002408089250912080734.

Exercise as a Therapeutic Intervention for Alzheimer's Disease

Hwang DJ, Cho JY.

Adv Neurobiol. 2025;44:297-316. doi: 10.1007/978-981-95-0066-6_16.

Perspectives on Alzheimer's Disease Treatment Based on Counteracting Oxidative Stress

Bilski R, Dąbkowski S, Kozieł I, Kozicki M, Małachowska A, Przygocki M, Tyska O.

Biomolecules. 2025 Sep 19;15(9):1345. doi: 10.3390/biom15091345.

Boosting Neurogenesis as a Strategy in Treating Alzheimer's Disease

Dwamena A, Beragama-Arachchi R, Wang H.

Int J Mol Sci. 2025 Sep 13;26(18):8926. doi: 10.3390/ijms26188926.

Chimeric Antigen Receptor Cell Therapy: Current Status and Its Potential in Aging and Alzheimer's Disease

Jurcau MC, Iovanovici CD, Jurcau A, Militaru M, Udrea RB, Comanescu A, Nunkoo VS.

Int J Mol Sci. 2025 Sep 16;26(18):9009. doi: 10.3390/ijms26189009.

The involvement of HIF-1α-dependent paracrine factors in Alzheimer's disease

Zhdankina VI, Perepelitsa ES, Blagova AV, Komleva YK, Baranich TI, Salmina AB.

Rev Neurosci. 2025 Oct 7;37(1):61-75. doi: 10.1515/revneuro-2025-0102. Print 2026 Jan 23.

[Disease-modifying therapy with lecanemab for early Alzheimer's dementia]

Hansen N, Wiltfang J.

Fortschr Neurol Psychiatr. 2025 Nov;93(11):453-460. doi: 10.1055/a-2681-4558. Epub 2025 Oct 6.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias